bexarotene targets LXR
Evidence from:
primary |
all sources
Evidence (1 sources)
New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy.
(2014)
PMID:25368578
cited
bexarotene, a retinoid X receptor agonist, stimulated clearance through the actions of liver X receptors
confidence: 0.93